WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

Alterations in ATC/DDD

 

Overview of ATC/DDD alterations decided at the two previous meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC/DDD alterations from the latest meeting (temporary codes) should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the alterations will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list. 

Please note that all ATC and DDD alterations are valid and implemented annually.

 

Change in ATC codes

INN/generic namePrevious ATC codeNew ATC codeDeadline for objection to temporary alterations 1) Implementation in ATC/DDD index
erenumabN02CX07N02CD0101.09.20192020
galcanezumabN02CX08N02CD0201.09.20192020
miltefosineL01XX09P01CX0401.09.20192020
1) Final: indicates that the date for objection has expired

Change of ATC level name

Previous nameNew ATC level nameATC codeDeadline for objection to temporary alterations 1) Implementation in ATC/DDD index
lactobacillus fermentumlactobacillusG01AX14Final2020
microspheres of human albuminperflutren, human albumin microspheresV08DA01Final2020
microspheres of phospholipidsperflutren, phospholipid microspheresV08DA04Final2020
sulfur hexafluoridesulfur hexafluoride, phospholipid microspheres V08DA05Final2020
perflubutane polymer microspheresperflubutane, phospholipid microspheresV08DA06Final2020
methylhomatropine and psycholepticshomatropine methylbromide and psycholepticsA03CB0401.09.20192020
Other hem productsHeme productsB06AB 01.09.20192020
hematinheminB06AB0101.09.20192020
1) Final: indicates that the date for objection has expired

Change of DDDs

ATC codeLevel namePrevious DDDNew DDDDeadline for objection to temporary alterations 1) Implementation in ATC/DDD index
A10BJ02liraglutide1.2 mg P1.5 mg PFinal2020

Last updated: 2019-05-02